However, the 2009 Asia-Pacific guidelines highlighted a similar efficacy for both 14-day triple therapy and bismuth containing quadruple in first line (Fock et al., 2009)
The two effects reinforce each other: you can train harder (MOTS-C), and recover better from harder training (GHK-Cu)
The experience was satisfying and the results were amazing
The animal literature is unusually consistent, though: nearly every published in vivo study used 5 mg/kg per injection, given three times on alternate days (days 1, 3, and 5, or days 14, 16, and 18 in the pulmonary fibrosis model), with effects tracked over the following three to four weeks
As a fragment of naturally occurring thymosin beta-4, the peptide aligns with endogenous human biology